On-Demand Webinar: Academic Creativity to Accelerate Technological Transfer for a COVID-19 Vaccine
Overview
Over the past 22 years, Texas Children’s Center for Vaccine Development at Baylor College of Medicine has acquired an international reputation as an academic-based product development partnership. Its mission is to advance vaccines for poverty-related neglected tropical diseases and emerging diseases.
In 2020, their team took advantage of their expertise in the field of SARS and MERS vaccine R&D to form a strategic global alliance to accelerate the design, engineering, process development, technological transfer and preclinical evaluation of a COVID-19 subunit vaccine. The goal was to advance a vaccine that is low-cost, affordable, safe, effective and globally accessible.
In this webinar, Maria Elena Bottazzi, Associate Dean of the National School of Tropical Medicine at Baylor College of Medicine, provides an overview of this program for a recombinant protein-based COVID-19 vaccine and its successful technological transfer for global access.
- Document Type: Webinar
- Watch time: 1 hour
- Webinar Speakers:
- Maria Elena Bottazzi, Associate Dean, National School of Tropical Medicine, Baylor College of Medicine
- Jeremy Petravicz, Senior Editor, Wiley
View This Webinar to Learn About:
- The program is focused on global morbidity diseases that affect around 400 million people worldwide.
- Academic research fills important gaps in translational research to identify targets, discover lead molecules and conduct clinical trials in connection with hospital systems.
- Prior expertise in coronaviruses and key partnerships helped in developing a multi-national strategy for the development and deployment of a COVID-19 vaccine.